Stiff Person Syndrome – Dual Treatment — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — A course of intravenous immunoglobulin delivered under neuroimmunology supervision
For function-limiting stiff-person syndrome despite symptomatic GABAergic therapy, IVIg has the strongest trial evidence for improvement in stiffness and spasm burden. Other immunotherapies may be considered in refractory disease through a specialist service.
Reference: Dalakas et al., high-dose intravenous immune globulin for stiff-person syndrome: https://pubmed.ncbi.nlm.nih.gov/11756576/